Previous 10 | Next 10 |
home / stock / polxf / polxf news
Polydex Pharmaceuticals ( OTCPK:POLXF ): Q3 GAAP EPS of $0.01. Revenue of $1.16M (-18.9% Y/Y) Press Release More news on: Polydex Pharmaceuticals Ltd., Earnings news and commentary, Healthcare stocks news, ,
TORONTO, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC/Pink:POLXF) announces 3 rd quarter financial results. Financial results for the third quarter of fiscal 2019, including the three-month and nine-month periods ended October 31, 2018, are shown together wit...
TORONTO, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC MKTS:POLXF) (the “Company”) operating as Dextran Products , today announced it has received two awards for water conservation efforts. For several years, Management has been focusing on m...
Polydex Pharmaceuticals ( OTCPK:POLXF ): Q2 GAAP EPS of $0.02. More news on: Polydex Pharmaceuticals Ltd., Earnings news and commentary, Healthcare stocks news, , Read more ...
TORONTO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC/Pink:POLXF) (the “Company”) today announced financial results for the second quarter of the 2019 fiscal year. The three-month and six-month periods ending July 31, 2018 (together with compa...
Polydex Pharmaceuticals ( OTCPK:POLXF ): Q1 EPS of $0.03 More news on: Polydex Pharmaceuticals Ltd., Earnings news and commentary, Healthcare stocks news, , Read more ...
TORONTO, June 15, 2018 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (Pink Sheets:POLXF) (the “Company”) reports financial results for the first quarter of fiscal 2019, the period ending April 30, 2018. All figures are reported in U.S. dollars. ...
TORONTO, May 01, 2018 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC/Pink:POLXF) (the “Company”) reports financial results for its fiscal year ended January 31, 2018. All figures are reported in U.S. dollars. Due to management’s efforts, gross margins hav...
Polydex Pharmaceuticals ( OTCPK:POLXF ): FY EPS of $0.13 Revenue of $5.28M (-20.2% Y/Y) Press Release More news on: Polydex Pharmaceuticals Ltd., Earnings news and commentary, Healthcare stocks news, ,
TORONTO, May 01, 2018 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC Pink:POLXF) (the “Company”) reports financial results for its fiscal year ended January 31, 2018. All figures are reported in U.S. dollars. Gross margins have been maintained and, combined with...
News, Short Squeeze, Breakout and More Instantly...
Polydex Pharms Ltd Company Name:
POLXF Stock Symbol:
OTCMKTS Market:
IDW Media Holdings, Inc. (IDWM) is expected to report for quarter end 2023-10-31 Deluxe Corporation (DLX) is expected to report $0.62 for Q4 2023 SkyWest Inc. (SKYW) is expected to report $0.11 for Q4 2023 1-800-FLOWERS.COM Inc. (FLWS) is expected to report $1.22 for Q2 2024 Brook...
Koss Corporation (KOSS) is expected to report for Q2 2024 Waterstone Financial Inc. (WSBF) is expected to report for Q4 2023 Silver Bull Resources Inc (SVBL) is expected to report for quarter end 2023-10-31 Xcel Energy Inc. (XEL) is expected to report $0.85 for Q4 2023 Sodexo ADR ...
Polydex Pharmaceuticals Inc (POLXF) is expected to report for quarter end 2023-10-31 RF Industries Ltd. (RFIL) is expected to report $-0.06 for Q4 2023 Northern Trust Corporation (NTRS) is expected to report $1.33 for Q4 2023 KeyCorp (KEY) is expected to report $0.22 for Q4 2023 S...